75Pharma Launches in the United Kingdom, redefining what it means to feel better
3.10.2025
FOR IMMEDIATE RELEASE
London, UK – October 2025
75Pharma Launches in the United Kingdom, redefining what it means to feel better.
London, UK – 75Pharma, a purpose-driven impact company in the pharmaceutical industry, proudly announces its official launch in the United Kingdom this October. Rooting for ethical innovation and sustainability, 75Pharma is on a mission to redefine what it means to feel better for people, communities, and the planet.
The launch in the UK marks the beginning of an exciting new chapter for 75Pharma. As the company expands its presence, it remains committed to delivering high-quality healthcare products while building a business designed for long-term, sustainable growth. By combining commercial ambition with a strong sense of responsibility, 75Pharma seeks to create lasting value for customers, communities, and the wider world.
Launching with purpose: 75Pharma Ibuprofen 400mg Soft Capsule
75Pharma’s UK debut product, 75Pharma Ibuprofen 400mg Soft Capsules, is a premium, rapid acting pain relief solution developed to the highest standards of efficacy and quality.
The product will be available at Boots from 13th October 2025, with wider retail and pharmacy distribution to follow later in the year.
Every aspect of 75Pharma’s product development and supply chain reflects its commitment to environmental, social, and governance (ESG) values. With European manufacturing, 75Pharma has sustainability embedded in its core operations, high precision, and uncompromised quality, supporting its vision for responsible, scalable growth.
Serving the conscious consumer: Responsibility as the new standard
Today’s health-conscious consumers expect more than efficacy; they seek authenticity, sustainability, and a clear sense of purpose. 75Pharma fully embraces this responsibility, helping to lead a shift toward a more transparent and ethical pharmaceutical industry.
By aligning its portfolio with the expectations of this emerging consumer majority, 75Pharma aims to deliver not only exceptional products but also a blueprint for what modern, responsible healthcare can look like.
Media & Partner Inquiries
75Pharma welcomes conversations with distributors, investors, healthcare providers, and media professionals.
- Sales & Distribution: sales@75pharmagroup.com
- Collaborations & Media: pr@75pharmagroup.com
- Investor Relations: investorrelations@75pharmagroup.com
- Website: www.75pharmagroup.com
About 75Pharma
75Pharma is an impact company built to create lasting change for people and the planet. With operations in London, Stockholm, and Helsinki, the company offers premium pharmaceutical products designed for conscious consumers who seek both therapeutic effectiveness and the opportunity to support ethical business practices. Its launch in the UK marks a significant step toward building a more responsible and sustainable pharmaceutical future, with further expansion as a first step into the Nordics planned as part of its broader European growth strategy.
75Pharma – A way to feel better